FDAnews Device Daily Bulletin

UROPLASTY ANNOUNCES APPOINTMENT OF NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER

May 19, 2006
A A

Uroplasty announced its board of directors has appointed David Kaysen as president and chief executive officer (CEO). Kaysen will also serve as a director of Uroplasty. Daniel Holman, chairman and interim president and CEO, will continue to serve as chairman.
PR Newswire